Catégorie
Regorafenib
Numéro CAS
755037-03-7
Formule moléculaire
C21H15ClF4N4O3
Masse moléculaire
482.82 g/mol
Synonyme

4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-[N'-(4-Chloro-3-trifluoromethylphenyl)ureido]-3-fluorophenoxy]pyridine-2-carboxylic Acid Methylamide;4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide;4-[4-[N'-(4-Chloro-3-trifluoromethylphenyl)ureido]-3-fluorophenoxy]pyridine-2-carboxylic Acid Methylamide;

Mots-clés
Amines
Aromatics
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1

Regorafenib is an oral multi-kinase inhibitor used to treat metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma after failure of prior therapies. It works by blocking multiple signaling pathways involved in tumor growth, angiogenesis, and metastasis. Common side effects include fatigue, hypertension, diarrhea, and hand–foot skin reactions.